SPL v2
SPL
SPL Set ID dc876b06-bc4e-3a00-e053-2a95a90afa6e
Route
TOPICAL
Published
Effective Date 2022-05-19
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Zinc Oxide (2.478 g)
Inactive Ingredients
Titanium Dioxide Tocopherol Sodium Phosphate, Dibasic, Anhydrous Ferrous Oxide Acrylic Acid/2-ethylhexyl Acrylate/styrene Copolymer (500000 Mw) Propylene Carbonate Edetate Disodium Anhydrous C13-16 Isoparaffin Mannitol Silicon Dioxide Acetyl Tetrapeptide-9 Palmitoyl Tripeptide-1 Butylene Glycol Peg-9 Polydimethylsiloxyethyl Dimethicone Alkyl (c12-15) Benzoate Isododecane Caprylyl Glycol Triethoxycaprylylsilane Ethyl Glycolate Butyloctyl Salicylate Triheptanoin C18-36 Acid Triglyceride Dimethicone/peg-10/15 Crosspolymer Dimethicone Alcohol Palmitoyl Tetrapeptide-7 Dimethicone Crosspolymer (450000 Mpa.s At 12% In Cyclopentasiloxane) Water Glycerin Bellis Perennis Hexamethylene Diisocyanate/trimethylol Hexyllactone Crosspolymer Quaternium-90 Bentonite Alpha-tocopherol Acetate Sodium Chloride Potassium Sorbate Triceteareth-4 Phosphate Cetyl Peg/ppg-10/1 Dimethicone (hlb 2) Polyglyceryl-3 Diisostearate Argan Oil Polyglyceryl-6 Polyricinoleate Xanthan Gum Phenoxyethanol Dimethicone/vinyl Dimethicone Crosspolymer (soft Particle) Sorbitan Monolaurate Octyldodecanol Levomenol Hexylene Glycol Dipropylene Glycol Phenylethyl Alcohol Sodium Citrate Potassium Chloride Potassium Phosphate, Dibasic

Identifiers & Packaging

Pill Appearance
Color: white Color: brown
Marketing Status
OTC MONOGRAPH FINAL Active Since 2022-04-13


Medication Information

Indications and Usage

Dosage and Administration

Section 50565-1

Section 51727-6

Section 51945-4

Section 55105-1

Section 55106-9


Structured Label Content

Indications and Usage (34067-9)

Dosage and Administration (34068-7)

Section 50565-1 (50565-1)

Section 51727-6 (51727-6)

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

Section 55106-9 (55106-9)


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)